OCULAR THERAPEUTIX, INC Shareholders' Equity
OCULAR THERAPEUTIX, INC (OCUL) had Shareholders' Equity of $520.04 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-03
- 2026-06-30: Stockholders' Equity Attributable to Parent $520.04M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $581.57M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $654.31M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $258.23M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $520.04M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $581.57M 10-Q · filed 2026-08-03 |
| 2025-12-31 | $654.31M 10-Q · filed 2026-08-03 |
| 2025-09-30 | $258.23M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $305.92M 10-Q · filed 2026-08-03 |
| 2025-03-31 | $265.93M 10-Q · filed 2026-08-03 |
| 2024-12-31 | $315.34M 10-Q · filed 2026-08-03 |
| 2024-09-30 | $352.02M 10-Q · filed 2025-11-04 |
| 2024-06-30 | $377.69M 10-Q · filed 2025-11-04 |
| 2024-03-31 | $407.98M 10-Q · filed 2025-11-04 |
| 2023-12-31 | $91.13M 10-K · filed 2026-02-05 |
| 2023-09-30 | $7.85M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $3.09M 10-Q · filed 2024-11-14 |
| 2023-03-31 | $9.71M 10-Q · filed 2024-11-14 |
| 2022-12-31 | $35.38M 10-K · filed 2026-02-05 |
| 2022-09-30 | $46.23M 10-Q · filed 2023-11-07 |
| 2022-06-30 | $65.80M 10-Q · filed 2023-11-07 |
| 2022-03-31 | $79.80M 10-Q · filed 2023-11-07 |
| 2021-12-31 | $88.00M 10-K · filed 2025-03-03 |
| 2021-09-30 | $87.34M 10-Q · filed 2022-11-07 |
| 2021-06-30 | $80.25M 10-Q · filed 2022-11-07 |
| 2021-03-31 | $83.41M 10-Q · filed 2022-11-07 |
| 2020-12-31 | $76.09M 10-K · filed 2024-03-11 |
| 2020-09-30 | -$4.13M 10-Q · filed 2021-11-08 |
| 2020-06-30 | $5.34M 10-Q · filed 2021-11-08 |
| 2020-03-31 | -$10.66M 10-Q · filed 2021-11-08 |
| 2019-12-31 | -$3.63M 10-K · filed 2023-03-06 |
| 2019-09-30 | $11.30M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $8.26M 10-Q · filed 2020-11-05 |
| 2019-03-31 | $25.65M 10-Q · filed 2020-11-05 |
| 2018-12-31 | $35.88M 10-K · filed 2022-02-28 |
| 2018-09-30 | $45.52M 10-Q · filed 2019-11-12 |
| 2018-06-30 | $45.73M 10-Q · filed 2019-11-12 |
| 2018-03-31 | $49.18M 10-Q · filed 2019-11-12 |
| 2017-12-31 | $26.15M 10-K · filed 2020-03-12 |
| 2017-09-30 | $35.92M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $48.02M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $63.91M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $52.01M 10-K · filed 2020-03-12 |
| 2016-09-30 | $62.29M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $70.45M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $80.17M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $89.59M 10-K · filed 2019-03-07 |
| 2015-09-30 | $98.81M 10-Q · filed 2015-11-10 |
| 2015-06-30 | $109.11M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $52.07M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $58.70M 10-K · filed 2018-03-08 |
| 2014-09-30 | $65.60M 10-Q · filed 2014-11-12 |
| 2014-06-30 | -$69.44M 10-Q · filed 2014-08-29 |
| 2013-12-31 | -$59.47M 10-K · filed 2017-03-10 |
| 2012-12-31 | -$46.61M 10-K · filed 2016-03-10 |
| 2011-12-31 | -$32.73M 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |